Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757)

Catalog No. T9901A-508 Copy Product Info
🥰Excellent
Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is a humanized antibody arm derived from the half-life extended bispecific T-cell engager (BiTE) AMG-757. This product specifically targets Delta-like ligand 3 (DLL3), a Notch pathway ligand highly expressed in small-cell lung cancer (SCLC) and other neuroendocrine tumors but minimally expressed in normal tissues. It binds to the extracellular domain of DLL3 with picomolar (pM) affinity. In a bispecific format, it facilitates the redirection of T cells to DLL3-positive tumor cells, inducing T-cell activation and the release of cytotoxic granules to exert potent anti-tumor effects.

Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757)

Copy Product Info
🥰Excellent
Catalog No. T9901A-508

Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is a humanized antibody arm derived from the half-life extended bispecific T-cell engager (BiTE) AMG-757. This product specifically targets Delta-like ligand 3 (DLL3), a Notch pathway ligand highly expressed in small-cell lung cancer (SCLC) and other neuroendocrine tumors but minimally expressed in normal tissues. It binds to the extracellular domain of DLL3 with picomolar (pM) affinity. In a bispecific format, it facilitates the redirection of T cells to DLL3-positive tumor cells, inducing T-cell activation and the release of cytotoxic granules to exert potent anti-tumor effects.

Anti-DLL3 Antibody
(anti-DLL3 arm derived from AMG-757)
Pack SizePriceUSA StockGlobal StockQuantity
1 mg$7222-4 weeks2-4 weeks
5 mg$1,9802-4 weeks2-4 weeks
10 mg$3,2602-4 weeks2-4 weeks
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) is a humanized antibody arm derived from the half-life extended bispecific T-cell engager (BiTE) AMG-757. This product specifically targets Delta-like ligand 3 (DLL3), a Notch pathway ligand highly expressed in small-cell lung cancer (SCLC) and other neuroendocrine tumors but minimally expressed in normal tissues. It binds to the extracellular domain of DLL3 with picomolar (pM) affinity. In a bispecific format, it facilitates the redirection of T cells to DLL3-positive tumor cells, inducing T-cell activation and the release of cytotoxic granules to exert potent anti-tumor effects.
Targets&IC50
DLL3 (human):0.64nM(Kd)
In vitro
The anti-DLL3 arm binds human DLL3 with high affinity (KD ≈ 0.64 nM). In T-cell and SCLC co-culture assays, the antibody redirects T cells, leading to robust activation (CD25/CD69 upregulation) and secretion of IFN-γ and TNF-α, which results in potent, dose-dependent lysis of DLL3-expressing tumor cells [1].
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetDLL3
Chemical Properties
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) | purchase Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) | Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) cost | order Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) | Anti-DLL3 Antibody (anti-DLL3 arm derived from AMG-757) in vitro